Index S&P 500 P/E 55.67 EPS (ttm) 1.38 Insider Own 0.14% Shs Outstand 1.27B Perf Week 2.37%
Market Cap 97.77B Forward P/E 9.40 EPS next Y 8.19 Insider Trans -0.41% Shs Float 1.27B Perf Month -4.16%
Enterprise Value 167.23B PEG 0.79 EPS next Q 2.24 Inst Own 89.96% Short Float 1.61% Perf Quarter -0.67%
Income 1.77B P/S 0.24 EPS this Y 6.19% Inst Trans 2.12% Short Ratio 2.45 Perf Half Y 17.57%
Sales 402.11B P/B 1.30 EPS next Y 14.33% ROA 0.68% Short Interest 20.35M Perf YTD -2.95%
Book/sh 59.18 P/C 9.17 EPS next 5Y 11.83% ROE 2.35% 52W High 85.15 -9.55% Perf Year 40.04%
Cash/sh 8.40 P/FCF 12.52 EPS past 3/5Y -24.70% -23.94% ROIC 1.18% 52W Low 54.06 42.47% Perf 3Y -14.10%
Dividend Est. 2.74 (3.56%) EV/EBITDA 9.68 Sales past 3/5Y 7.60% 8.40% Gross Margin 13.78% Volatility 4.37% 3.39% Perf 5Y 4.65%
Dividend TTM 2.66 (3.45%) EV/Sales 0.42 EPS Y/Y TTM -61.77% Oper. Margin 3.15% ATR (14) 2.71 Perf 10Y -17.95%
Dividend Ex-Date Jan 22, 2026 Quick Ratio 0.63 Sales Y/Y TTM 7.89% Profit Margin 0.44% RSI (14) 48.32 Recom 1.63
Dividend Gr. 3/5Y 5.74% 5.87% Current Ratio 0.84 EPS Q/Q 76.77% SMA20 -1.01% Beta 0.50 Target Price 95.17
Payout 191.23% Debt/Eq 1.06 Sales Q/Q 8.38% SMA50 -1.83% Rel Volume 1.28 Prev Close 75.70
Employees 300000 LT Debt/Eq 0.99 Earnings Feb 10 BMO SMA200 6.33% Avg Volume 8.31M Price 77.02
IPO Oct 01, 1952 Option/Short Yes / Yes EPS/Sales Surpr. 8.73% 1.92% Trades
Volume 10,624,041 Change 1.74%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-14-25 Initiated Goldman
Buy
$91
Aug-18-25 Upgrade UBS
Neutral → Buy
$79
Aug-14-25 Upgrade Robert W. Baird
Neutral → Outperform
$82
Feb-13-25 Upgrade Leerink Partners
Market Perform → Outperform
$55 → $75
Feb-12-25 Upgrade Cantor Fitzgerald
Neutral → Overweight
Jan-30-25 Upgrade Edward Jones
Hold → Buy
Dec-03-24 Upgrade Deutsche Bank
Hold → Buy
$66
Nov-18-24 Upgrade Wells Fargo
Equal Weight → Overweight
$60 → $66
Oct-10-24 Upgrade Barclays
Equal Weight → Overweight
$63 → $82
Oct-04-24 Upgrade TD Cowen
Hold → Buy
$59 → $85
May-30-24 Initiated Robert W. Baird
Neutral
$61
May-07-24 Downgrade TD Cowen
Buy → Hold
$99 → $59
May-02-24 Downgrade UBS
Buy → Neutral
$85 → $60
May-01-24 Downgrade Leerink Partners
Outperform → Market Perform
$87 → $60
May-01-24 Downgrade Cantor Fitzgerald
Overweight → Neutral
Mar-06-24 Initiated Barclays
Equal Weight
$78
Feb-26-24 Initiated Leerink Partners
Outperform
$88
Dec-22-23 Initiated HSBC Securities
Buy
$94
Sep-19-23 Upgrade Evercore ISI
In-line → Outperform
$81 → $83
Sep-12-23 Upgrade Wolfe Research
Peer Perform → Outperform
$80
Show Previous Ratings
Feb-11-26 02:32PM
09:47AM
07:04AM
04:58AM
12:33AM
10:07PM
Loading…
Feb-10-26 10:07PM
05:15PM
04:31PM
04:24PM
04:23PM
(The Wall Street Journal)
04:11PM
04:03PM
03:43PM
02:13PM
02:02PM
12:53PM
Loading…
12:53PM
11:43AM
10:59AM
10:58AM
10:04AM
09:47AM
09:47AM
09:34AM
09:34AM
09:34AM
09:30AM
08:50AM
08:35AM
08:15AM
07:40AM
07:24AM
Loading…
07:24AM
07:19AM
07:12AM
06:53AM
06:48AM
06:42AM
06:41AM
(Associated Press Finance)
06:37AM
(The Wall Street Journal)
06:34AM
06:30AM
06:00AM
04:27AM
Feb-09-26 07:55PM
11:30AM
08:26AM
06:23AM
Feb-08-26 10:05PM
02:00PM
Feb-06-26 08:37PM
04:08PM
01:52PM
Feb-05-26 04:00PM
12:49PM
12:48PM
11:13AM
09:15AM
08:01AM
08:00AM
07:00AM
Feb-04-26 05:45PM
01:15PM
11:30AM
08:47AM
06:46AM
Feb-03-26 04:49PM
(The Wall Street Journal)
10:00AM
07:55AM
03:08AM
Feb-02-26 07:15AM
05:47AM
Feb-01-26 05:30PM
Jan-31-26 09:35AM
07:47AM
Jan-30-26 02:23PM
09:40AM
Jan-29-26 10:38AM
09:13AM
02:19AM
Jan-28-26 05:45PM
12:35PM
12:24PM
12:07PM
07:42AM
05:30AM
(The Wall Street Journal)
03:20AM
(The Wall Street Journal)
Jan-27-26 11:31PM
07:13PM
07:06PM
05:34PM
(The Wall Street Journal)
05:33PM
(The Wall Street Journal)
05:12PM
04:54PM
(The Wall Street Journal)
04:44PM
04:44PM
04:41PM
04:38PM
04:37PM
04:17PM
(The Wall Street Journal)
04:15PM
04:13PM
(The Wall Street Journal)
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Finucane Anne A. Director Aug 20 '25 Sale 71.02 7,500 532,650 22,156 Aug 29 04:29 PM Finucane Anne A. Director Aug 20 '25 Proposed Sale 70.97 7,500 532,275 Aug 19 06:57 PM SANSONE GUY P Director Jun 05 '25 Buy 63.70 1,570 100,009 12,007 Jun 09 08:22 AM ROBBINS LARRY Director May 02 '25 Sale 67.86 2,276,068 154,444,758 9,670,731 May 06 04:15 PM ROBBINS LARRY Director May 05 '25 Sale 67.41 1,323,932 89,249,945 8,346,799 May 06 04:15 PM ROBBINS LARRY Director May 06 '25 Sale 66.67 150,000 10,000,710 8,196,799 May 06 04:15 PM Shah Prem S EVP and Group President Mar 17 '25 Option Exercise 62.21 846 52,630 43,190 Mar 18 04:51 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Option Exercise 62.21 7,513 467,384 15,907 Mar 07 04:56 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Sale 66.35 7,513 498,488 8,394 Mar 07 04:56 PM Clark James David Officer Mar 05 '25 Proposed Sale 66.35 7,513 498,489 Mar 05 05:25 PM Mahoney Michael F Director Feb 18 '25 Buy 66.70 30,000 2,001,000 39,356 Feb 19 12:35 PM
